Important note: Information in this article was accurate in 2000. The state of the art may have changed since the publication date.
Epidemiological features of drug resistant tuberculosis in Harare, 1994 to 1996.
Cent Afr J Med. 1999 Nov;45(11):282-7. Unique Identifier : AIDSLINE MED/20350373 Makombe RR; Easterbrook PJ; Lowe O; Ferguson AD; Neill P; Ndudzo A; van der Have JJ; Mbengeranwa OL; Beatrice Road Infectious Diseases Hospital, City Health; Department, Harare, Zimbabwe.
Abstract:
OBJECTIVES: To characterise the prevalence, clinical and radiological features of drug resistant tuberculosis in selected patients with pulmonary tuberculosis in Harare between 1994 and 1996. DESIGN: A retrospective review of medical and microbiological records. SETTING: Beatrice Road Infectious Diseases Hospital, Harare, Zimbabwe. SUBJECTS: 381 smear-positive tuberculosis patients who had samples submitted to the National Tuberculosis Reference Laboratory for culture and susceptibility testing. MAIN OUTCOME MEASURES: Prevalence of resistance of isolated cultures of Mycobacterium tuberculosis to anti-tuberculosis drugs; clinical, radiological and microbiological response to treatment with recommended anti-tuberculosis regimens. RESULTS: Resistance to one or more drugs was detected in 16 isolates (16/165, 9.7%), single drug resistance in five (3.0%) and resistance to two or more drugs in 11 (6.7%). There were no distinctive clinical or radiological features of drug-resistant tuberculosis, although a higher percent of drug resistant cases had evidence of pleural disease (25% vs 2.5%, p = 0.005). Neither past history of tuberculosis or known or suspected HIV infection was associated with the presence of drug resistance. CONCLUSIONS: In spite of the resurgence of tuberculosis and the high prevalence of HIV infection in Zimbabwe, the rates of drug resistance have remained relatively low, even among a selected population at high risk of resistance. A significant proportion of cases of drug-resistant tuberculosis appear to be due to new transmission of drug resistant strains, which reinforces the importance of maintaining a surveillance system for the monitoring of drug susceptibility. Ongoing prospective studies should provide more reliable estimates of the prevalence and determinants of drug resistance in Zimbabwe.
Keywords: JOURNAL ARTICLE Adolescence Adult Aged Aged, 80 and over Child *Drug Resistance, Microbial Female Human HIV Infections/MICROBIOLOGY Male Middle Age Prevalence Retrospective Studies Risk Factors Support, Non-U.S. Gov't Tuberculosis, Pulmonary/COMPLICATIONS/DRUG THERAPY/*EPIDEMIOLOGY/ RADIOGRAPHY Zimbabwe/EPIDEMIOLOGY 001030
A00A1089
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from
Elton John AIDS Foundation,
the National Library of Medicine,
and donations from users like you. Always watch for outdated information. This article first appeared in 2000. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Important note: Information in this article was accurate in 2000. The state of the art may have changed since the publication date.
